In{uFB02}uence of obesity on propofol pharmacokinetics in patients undergoing cardiac surgery using cardiopulmonary bypass : (Record no. 59566)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03488cam a2200349 a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | EG-GiCUC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250223031643.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 170123s2016 ua f m 000 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | EG-GiCUC |
Language of cataloging | eng |
Transcribing agency | EG-GiCUC |
041 0# - LANGUAGE CODE | |
Language code of text/sound track or separate title | eng |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | Deposite |
097 ## - Thesis Degree | |
Thesis Level | M.Sc |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
Classification number | Cai01.08.08.M.Sc.2016.Em.I |
100 0# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Eman Ali Ali Ibrahim Elbaraky |
245 10 - TITLE STATEMENT | |
Title | In{uFB02}uence of obesity on propofol pharmacokinetics in patients undergoing cardiac surgery using cardiopulmonary bypass : |
Remainder of title | Derivation of a pharmacokinetic model / |
Statement of responsibility, etc. | Eman Ali Ali Ibrahim Elbaraky ; Supervised Nirmeen Sabry , Maggie Abbassi , Tarek Marei |
246 15 - VARYING FORM OF TITLE | |
Title proper/short title | {uFE97}{uFE84}{uFE9B}{uFEF3}{uFEAD} {uFE8D}{uFEDF}{uFEB3}{uFEE3}{uFEE7}{uFE94} {uFECB}{uFEE0}{uFEF0} {uFE8D}{uFEDF}{uFEA3}{uFEAD}{uFEDB}{uFEF3}{uFE94} {uFE8D}{uFEDF}{uFEA9}{uFEED}{uFE8D}{uFE8B}{uFEF3}{uFE94} {uFEDF}{uFECC}{uFED8}{uFE8E}{uFEAD} {uFE8D}{uFEDF}{uFE91}{uFEAD}{uFEED}{uFE91}{uFEED}{uFED3}{uFEED}{uFEDD} فى {uئإإ٣}{uئإءؤ}{uئإآئ}{uئإئ٠} {uئإ٩ئ}{uئإءؤ}{uئإ٨ؤ}{uئإء٣}{uئإ٨إ}{uئإ٩٥} {uئإ٨ؤ}{uئإؤئ}{uئإؤ٨}{uئإإ٠}{uئإ٨ئ} {uئإ٨ؤ}{uئإؤئ}{uئإإ٣}{uئإؤ٤}{uئإ٩٧}{uئإإؤ}{uئإء١} {uئإ٩١}{uئإ٨إ}{uئإآ٣}{uئإ٩٧}{uئإء٧}{uئإء٩}{uئإ٨ؤ}{uئإإ١} {uئإ٨ؤ}{uئإؤئ}{uئإ٩٧}{uئإء٣}{uئإإؤ}{uئإئ٣}{uئإؤؤ} {uئإ٨ؤ}{uئإؤئ}{uئإؤ٨}{uئإإ٠}بى {uئإ٨ؤ}{uئإؤئ}{uئإءؤ}{uئإ٨آ}{uئإإؤ}ى {uئإئآ}{uئإآ٣}{uئإ٩٧}{uئإء٧}{uئإئأ}{uئإآ٩} {uئإإ٧}{uئإإ٣}{uئإإؤ}{uئإءآ}{uئإ٩ؤ} {uئإؤئ}{uئإإ٠}{uئإء٣}{uئإءؤ}{uئإؤآ}{uئإئ٣}{uئإ٩٤} {uئإ٨ؤ}{uئإؤئ}{uئإء٩}{uئإإؤ}{uئإ٨ؤ}{uئإ٨آ}{uئإئ٣}{uئإ٩٤} |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Cairo : |
Name of publisher, distributor, etc. | Eman Ali Ali Ibrahim Elbaraky , |
Date of publication, distribution, etc. | 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 93 P. ; |
Dimensions | 25cm |
502 ## - DISSERTATION NOTE | |
Dissertation note | Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Propofol is a general anaesthetic drug used in many types of surgeries for its favourable pharmacokinetic (PK) properties; lack of accumulation and rapid emergence of patients from anaesthesia. Many factors can independently affect propofol pharmacokinetics such as obesity, cardiopulmonary bypass (CPB), hypoalbuminemia, hypothermia and critical illness. The incidence of obesity is tremendously increasing worldwide and more and more obese patients are expected to undergo cardiac surgeries adopting CPB. Yet, the available PK models that describe propofol pharmacokinetics during CPB did not investigate the influence of both obesity and CPB on propofol pharmacokinetics. Therefore, available PK models describing propofol pharmacokinetics in non-obese patients during CPB cannot be safely extrapolated to obese patients undergoing the same type of surgery. To investigate the influence of obesity on propofol pharmacokinetics during CPB, derive and evaluate a descriptive and predictive PK model to validate its use in obese and non-obese patients undergoing cardiac surgery adopting hypothermic CPB |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
Additional physical form available note | Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Cardiopulmonary bypass |
653 #4 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Pharmacokinetics |
653 #4 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Propofol |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Maggie Abbassi , |
Relator term | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nirmeen Sabry , |
Relator term | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tarek Marei , |
Relator term | |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a> |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
Cataloger | Nazla |
Reviser | Revisor |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
Cataloger | Samia |
Reviser | Cataloger |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Koha item type | Thesis |
Source of classification or shelving scheme | Not for loan | Home library | Current library | Date acquired | Full call number | Barcode | Date last seen | Koha item type | Copy number |
---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | قاعة الرسائل الجامعية - الدور الاول | 11.02.2024 | Cai01.08.08.M.Sc.2016.Em.I | 01010110070784000 | 22.09.2023 | Thesis | ||
Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | مخـــزن الرســائل الجـــامعية - البدروم | 11.02.2024 | Cai01.08.08.M.Sc.2016.Em.I | 01020110070784000 | 22.09.2023 | CD - Rom | 70784.CD |